Curis Lifescien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1BZN01016
  • NSEID: CURIS
  • BSEID:
INR
92.00
0.2 (0.22%)
BSENSE

Mar 27

BSE+NSE Vol: 7000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.0 k (-43.55%) Volume

Shareholding (Oct 2025)

FII

0.00%

Held by 0 FIIs

DII

7.32%

Held by 0 DIIs

Promoter

92.68%

Which are the latest news on Curis Lifescien.?

27-Mar-2026
No latest news for Curis Lifescien. found.

Why is Curis Lifesciences Ltd falling/rising?

27-Mar-2026

As of 26-Mar, Curis Lifesciences Ltd's stock price is currently at 91.80, reflecting a 3.32% increase today. However, the stock has declined significantly year-to-date and is trading below its moving averages, indicating a bearish trend and reduced investor confidence.

As of 26-Mar, Curis Lifesciences Ltd's stock price is rising, currently at 91.80, reflecting an increase of 2.95 or 3.32%. This rise is notable as it outperformed the sector by 1.43% today. However, it is important to consider the broader context of the stock's performance. Over the past week, the stock has decreased by 0.92%, and over the past month, it has fallen by 4.38%. Year-to-date, the stock has experienced a significant decline of 23.88%, compared to a 10.80% drop in the benchmark Sensex.<BR><BR>Despite the current increase, Curis Lifesciences Ltd is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a generally bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume on 24 March falling by 74.36% against the 5-day average. This decline in participation could suggest a lack of confidence among investors, despite the recent price increase. <BR><BR>In summary, while the stock is experiencing a rise today, the overall trend remains concerning due to previous declines and reduced investor activity.

View full answer

Why is Curis Lifesciences Ltd falling/rising?

28-Mar-2026

As of 27-Mar, Curis Lifesciences Ltd's stock price is rising to 92.00, reflecting a 0.22% increase, driven by strong investor participation and relative outperformance in its sector, despite a decline over the past month and year-to-date. The stock's current performance suggests a positive shift in market sentiment, indicating potential for recovery.

As of 27-Mar, Curis Lifesciences Ltd's stock price is rising, currently at 92.00, reflecting a change of 0.2 (0.22%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.09% today, indicating a relative strength compared to its peers. Additionally, there has been a significant rise in investor participation, with a delivery volume of 33,000 shares on March 25, which is a 400% increase compared to the 5-day average delivery volume. <BR><BR>While the stock has shown a decline of 6.12% over the past month and a year-to-date drop of 23.71%, the current upward movement suggests a positive shift in market sentiment or trading activity. Furthermore, the stock is trading higher than its 5-day moving averages, although it remains below the longer-term moving averages (20-day, 50-day, 100-day, and 200-day), indicating potential for recovery. Overall, the combination of today's performance and increased trading activity contributes to the stock's rising price.

View full answer

Why is Curis Lifesciences Ltd falling/rising?

29-Mar-2026

As of 28-Mar, Curis Lifesciences Ltd's stock price is rising to 92.00, driven by strong investor interest and a 0.22% increase today. However, it has declined 23.71% year-to-date, indicating ongoing long-term challenges despite the recent uptick.

As of 28-Mar, Curis Lifesciences Ltd's stock price is rising, currently at 92.00, with a change of 0.2 (0.22%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.09% today, indicating a relative strength compared to its peers. Additionally, there has been a notable increase in investor participation, with delivery volume on 25 March rising by 400% against the 5-day average, suggesting heightened interest and confidence among investors.<BR><BR>Despite the positive movement today, it is important to note that the stock has experienced a decline of 23.71% year-to-date, which contrasts with the Sensex's decline of 12.67% during the same period. The stock's performance over the last month shows a decrease of 6.12%, while the benchmark has fallen by 9.37%. This indicates that while the stock is currently experiencing a rise, it has faced significant challenges in the longer term.<BR><BR>In terms of moving averages, the stock is currently higher than its 5-day moving average but lower than the 20-day, 50-day, 100-day, and 200-day moving averages, which may suggest that while there is a short-term upward trend, it has not yet regained its longer-term momentum. Overall, the combination of today's positive performance and increased investor activity contributes to the current rise in Curis Lifesciences Ltd's stock price.

View full answer

Why is Curis Lifesciences Ltd falling/rising?

30-Mar-2026

As of 29-Mar, Curis Lifesciences Ltd's stock price is rising to 92.00, driven by increased investor participation and sector outperformance. However, it has declined 23.71% year-to-date, indicating mixed signals for its longer-term trend.

As of 29-Mar, Curis Lifesciences Ltd's stock price is rising, currently at 92.00, with a change of 0.2 (0.22%) increase. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.09% today, indicating a relatively strong performance compared to its peers. Additionally, there has been a notable increase in investor participation, with the delivery volume on 25 March rising by 400% against the 5-day average, suggesting heightened interest and confidence among investors. <BR><BR>However, it is important to note that while the stock is experiencing a short-term rise, its year-to-date performance shows a decline of 23.71%, which is significantly worse than the Sensex's decline of 12.67% over the same period. The stock is currently higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed signals regarding its longer-term trend. Overall, the current rise in price appears to be driven by short-term factors, particularly increased trading activity and sector outperformance.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 77 Cr (Micro Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.72

stock-summary
Return on Equity

30.38%

stock-summary
Price to Book

3.63

Revenue and Profits:
Net Sales:
20 Cr
(Quarterly Results - Jun 2025)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.43%
0%
-21.43%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Curis Lifescien. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.25
Debt to EBITDA (avg)
1.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.50
Tax Ratio
30.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.79%
ROCE (avg)
30.11%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
3.64
EV to EBIT
8.86
EV to EBITDA
8.30
EV to Capital Employed
2.53
EV to Sales
1.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
28.59%
ROE (Latest)
30.38%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
No Trend
OBV
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Oct 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Pawasia Siddhant J (19.05%)

Highest Public shareholder

Strategic Sixth Sense Capital Fund (2.04%)

Individual Investors Holdings

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.50",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.23",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.87",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Curis Lifescien."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Curis Lifescien."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Curis Lifescien."
  }
]

Quarterly Results Snapshot (Standalone) - Jun'25 - QoQstock-summary

Jun'25
Change(%)
Net Sales
19.50
NA
NA
Operating Profit (PBDIT) excl Other Income
4.23
NA
NA
Interest
0.29
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
2.87
NA
NA
Operating Profit Margin (Excl OI)
21.69%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Curis Lifesciences Ltd stock-summary
stock-summary
Curis Lifesciences Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of "M/s Loreto Pharmaceutacals", pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter " M/s Loreto Pharmaceutacals" was converted from Partnership Firm to a Private Limited Company as "Curis Lifesciences Private Limited" and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available